Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Profit & Loss 
Valuation 
Analyst Note 
Balance Sheet 
Cash Flow 
Financial Ratio 
Qtr. Results 
News 
About
Zydus Wellness Ltd (ZYDUSWELL)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 531335 NSE: ZYDUSWELL Consumer Food | Small Cap | Zydus Wellness Share Price
₹572 -20.10 (-3.39%)
As on 22-Jul'26 15:40
Zydus Wellness Ltd (ZYDUSWELL)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 531335 NSE: ZYDUSWELL Consumer Food | Small Cap | Zydus Wellness Share Price
₹572 -20.10 (-3.39%)
As on 22-Jul'26 15:40
Key Metrics
Valuation Multiples
Market Cap
₹18,838 Cr.
Current Price
₹572
52-Week Low / High
₹358 / 611
TTM EPS
₹6.2
TTM Sales
₹3,961 Cr.
Book Value per Share
₹183.1
P/E Ratio
95.53
Higher than its 5-year historical median
Industry PE
55.9
Price to Book (P/B)
3.23
Higher than its 5-year historical median
Price to Sales (P/S)
4.76
In line with its 5-year historical median
EV/EBITDA
42.46
Higher than its 5-year historical median
Dividend Yield
0.21%
Profitability Efficiency
Return on Equity (ROE)
3.43%
Underperforms industry median
Return on Capital Employed (ROCE)
4.42%
Underperforms industry median
Return on Assets (ROA)
2.39%
Operating Profit Margin
12.7%
Net Profit Margin
4.98%
Gross Profit Margin
10%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
46.22%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
32.57%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
-43.15%
Asset Quality
Promoter Holding
69.64%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹5,762 Cr.
Equity
₹63.6 Cr.
Face Value
₹2
All Time Low / High
₹0.41 / 610.95
Check Before You Invest
Quality
Somewhat GoodValuation
UndervaluedCheck Valuation charts
Price Trend
Strong
Is Zydus Wellness Ltd a good quality company?
Zydus Wellness Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Zydus Wellness Ltd performance compare with that of its Peers?
Revenue growth of Zydus Wellness Ltd vs industry peers?
Zydus Wellness Ltd revenue CAGR is 8.92%, compared to the industry median CAGR of 7.03%, indicating faster growth and gaining its market share.
Promoter shareholding and pledge status of Zydus Wellness Ltd?
Promoters hold 69.64% of the Zydus Wellness Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Zydus Wellness Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 12.4% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Zydus Wellness Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 23.5% | 23.3% | 7.1% | 5.3% | 3.9% | 6.4% | 5.8% | 5.1% | 6.4% | 4.4% | - |
| Value Creation Index ⓘ | 0.7 | 0.7 | -0.5 | -0.6 | -0.7 | -0.5 | -0.6 | -0.6 | -0.5 | -0.7 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 431 | 513 | 843 | 1,767 | 1,867 | 2,009 | 2,255 | 2,328 | 2,709 | 3,961 | 3,961 |
| Sales YoY Gr. | - | 19.1% | 64.4% | 109.6% | 5.7% | 7.6% | 12.2% | 3.2% | 16.4% | 46.2% | - |
| Adj EPS ⓘ | 5.5 | 6.7 | 5.7 | 5.9 | 6.6 | 9.7 | 10 | 8.7 | 10.8 | 6.9 | 6.2 |
| YoY Gr. | - | 21.5% | -15.8% | 3.4% | 13.3% | 46.5% | 2.3% | -13.1% | 24.6% | -35.6% | - |
| BVPS (₹) ⓘ | 28.5 | 35.4 | 117.5 | 120 | 143.6 | 152.3 | 161.1 | 168.5 | 178.4 | 183.2 | 183.1 |
| Adj Net Profit ⓘ | 108 | 132 | 164 | 169 | 211 | 310 | 317 | 275 | 343 | 221 | 197 |
| Cash Flow from Ops. ⓘ | 77 | 69.1 | 149 | 259 | 287 | 237 | 91.7 | 246 | 380 | 226 | - |
| Debt/CF from Ops. ⓘ | 0.3 | 0.4 | 10.5 | 5.9 | 1.9 | 1.6 | 3.2 | 1.3 | 0.5 | 14.1 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 28% | 16.2% | 20.7% | 46.2% | ||||
| Adj EPS ⓘ | 2.5% | 0.9% | -11.3% | -35.6% | ||||
| BVPSⓘ | 23% | 5% | 4.4% | 2.7% | ||||
| Share Price | 13.8% | 5.2% | 24.6% | 39.2% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 20.9 | 21.1 | 8 | 4.9 | 5.3 | 6.6 | 6.4 | 5.3 | 6.2 | 3.8 | 3.4 |
| Op. Profit Mgn % ⓘ | 23.1 | 24.4 | 21.9 | 18.2 | 18.5 | 17.1 | 15 | 13.2 | 14 | 12.7 | 12.8 |
| Net Profit Mgn % ⓘ | 25.7 | 26.2 | 19.7 | 9.6 | 11.3 | 15.4 | 14 | 11.8 | 12.7 | 5.6 | 5 |
| Debt to Equity ⓘ | 0 | 0 | 0.5 | 0.4 | 0.1 | 0.1 | 0.1 | 0.1 | 0 | 0.6 | 0.5 |
| Working Cap Days ⓘ | 55 | 50 | 142 | 110 | 110 | 114 | 118 | 128 | 122 | 109 | 62 |
| Cash Conv. Cycle ⓘ | -51 | -45 | -67 | -45 | -34 | -9 | 24 | 39 | 38 | 44 | 29 |
Profit And Loss
(All Figures are in Crores.)| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 431 | 513 | 843 | 1,767 | 1,867 | 2,009 | 2,255 | 2,328 | 2,709 | 3,961 |
| Operating Expenses ⓘ + | 332 | 387 | 658 | 1,446 | 1,522 | 1,667 | 1,918 | 2,020 | 2,330 | 3,459 |
| Operating Profit ⓘ | 99 | 125 | 185 | 321 | 344 | 342 | 337 | 308 | 379 | 502 |
| Operating Profit Margin (%) | 23.0% | 24.4% | 21.9% | 18.2% | 18.4% | 17.0% | 15.0% | 13.2% | 14.0% | 12.7% |
| Other Income ⓘ + | 33 | 35 | 39 | 11 | 9 | 13 | 5 | 14 | 14 | 14 |
| Interest ⓘ | 1 | 2 | 30 | 140 | 84 | 26 | 16 | 24 | 12 | 98 |
| Depreciation ⓘ | 7 | 9 | 13 | 26 | 25 | 24 | 25 | 24 | 28 | 147 |
| Profit Before Tax ⓘ | 124 | 150 | 171 | 121 | 112 | 306 | 291 | 260 | 359 | 231 |
| Tax ⓘ | 13 | 13 | -1 | -20 | -7 | -3 | -20 | -7 | 12 | 33 |
| Profit After Tax | 111 | 137 | 171 | 142 | 119 | 309 | 310 | 267 | 347 | 197 |
| PAT Margin (%) | 25.8% | 26.6% | 20.3% | 8.0% | 6.4% | 15.4% | 13.8% | 11.5% | 12.8% | 5.0% |
| Adjusted EPS (₹) | 5.6 | 6.9 | 5.9 | 4.9 | 3.7 | 9.7 | 9.8 | 8.4 | 10.9 | 6.2 |
| Dividend Payout Ratio (%) | 23.30% | 23.30% | 17.10% | 20.30% | 26.80% | 10.30% | 10.20% | 11.90% | 11% | 19.40% |
Valuation of Zydus Wellness - Consolidated
Analyst's Notes
No data found!
Balance Sheet
(All Figures are in Crores.)| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 557 | 691 | 3,386 | 3,461 | 4,568 | 4,844 | 5,123 | 5,358 | 5,672 | 5,826 | |
| Debt + | 25 | 25 | 1,569 | 1,519 | 550 | 132 | 230 | 324 | 185 | 3,185 | |
| Minority Interest | 11 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Trade Payables | 67 | 79 | 392 | 504 | 439 | 364 | 313 | 363 | 429 | 461 | |
| Others Liabilities ⓘ | -33 | -53 | 8 | -15 | -16 | 311 | 18 | -52 | 12 | 718 | |
| Total Liabilities ⓘ | 626 | 755 | 5,356 | 5,469 | 5,540 | 5,651 | 5,684 | 5,992 | 6,297 | 10,190 | |
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 103 | 104 | 4,567 | 4,674 | 4,667 | 4,710 | 4,732 | 4,708 | 5,125 | 8,596 | |
| CWIP ⓘ | 0 | 0 | 10 | 4 | 4 | 12 | 13 | 10 | 15 | 23 | |
| Investments ⓘ | 30 | 148 | 46 | 110 | 0 | 27 | 70 | 78 | 36 | 5 | |
| Inventories | 32 | 35 | 233 | 292 | 365 | 362 | 458 | 468 | 518 | 764 | |
| Trade Receivables | 4 | 9 | 96 | 118 | 94 | 142 | 208 | 283 | 367 | 384 | |
| Cash Equivalents | 440 | 414 | 164 | 82 | 253 | 170 | 38 | 240 | 74 | 111 | |
| Others Assets ⓘ | 17 | 46 | 238 | 188 | 157 | 228 | 165 | 207 | 162 | 307 | |
| Total Assets ⓘ | 626 | 755 | 5,356 | 5,469 | 5,540 | 5,651 | 5,684 | 5,992 | 6,297 | 10,190 | |
Cash Flow
(All Figures are in Crores.)| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 77 | 69 | 149 | 259 | 287 | 237 | 92 | 246 | 380 | 226 |
| Cash Flow From Investing Activity ⓘ + | -72 | -59 | -4,162 | -17 | -10 | -86 | -85 | -178 | -224 | -2,910 |
| Cash Flow From Financing Activity ⓘ + | -6 | -2 | 4,052 | -260 | -216 | -234 | -139 | -26 | -186 | 2,698 |
| Net Cash Flow ⓘ | -1 | 8 | 39 | -18 | 60 | -83 | -132 | 43 | -30 | 15 |
Financial Ratio
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 21.49 | 21.87 | 8.4 | 4.14 | 2.96 | 6.56 | 6.23 | 5.09 | 6.29 | 3.43 |
| ROCE (%) | 23.48 | 23.33 | 7.08 | 5.26 | 3.88 | 6.41 | 5.77 | 5.12 | 6.43 | 4.42 |
| Asset Turnover Ratio | 0.77 | 0.75 | 0.28 | 0.36 | 0.37 | 0.38 | 0.43 | 0.43 | 0.48 | 0.51 |
| PAT to CFO Conversion(x) | 0.69 | 0.5 | 0.87 | 1.82 | 2.41 | 0.77 | 0.3 | 0.92 | 1.1 | 1.15 |
| Working Capital Days | ||||||||||
| Receivable Days | 2.70 | 4.50 | 22.70 | 20.30 | 19.30 | 20.10 | 26.40 | 36 | 40.40 | 32.80 |
| Inventory Days | 22.10 | 23.40 | 58.10 | 49.70 | 59.60 | 61.60 | 61.80 | 67.80 | 61.20 | 55.90 |
| Payable Days | 257.40 | 234.50 | 397.10 | 210.20 | 203.70 | 149.50 | 107.90 | 108.40 | 113.10 | 103.70 |
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Zydus Wellness Ltd FAQs
The current trading price of Zydus Wellness on 22-Jul-2026 15:40 is ₹572.0.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Jul-2026 the market cap of Zydus Wellness stood at ₹18,838.3 Cr
The latest P/E ratio of Zydus Wellness as of 21-Jul-2026 is 501.0.
The latest P/B ratio of Zydus Wellness as of 21-Jul-2026 is 4.67.
The 52-week high of Zydus Wellness is ₹611.0 and the 52-week low is ₹357.6.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Zydus Wellness is ₹582 ( Cr.) .
Past 10 year's financial track record analysis by Moneyworks4me indicates that Zydus Wellness Ltd is a average quality company.
The key valuation ratios of Zydus Wellness Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Zydus Wellness Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing
About Zydus Wellness Ltd
Zydus Wellness Ltd. is established in 1988. The company is a leading consumer wellness company with an Indian heritage and a global footprint. It believes, a healthy lifestyle is not just about being active but also about feeling good from within. So, it approaches health and wellness in a holistic manner. It nourishes, nurture and energize millions of lives by offering a variety of innovative, industry-leading products. With several years of operational excellence, it has seven leading brands in its portfolio, namely Complan, Sugar Free, Glucon-D, Everyuth, Nycil, Sugarlite and Nutralite.
Headquartered in Ahmedabad and Mumbai, it has many manufacturing facilities across several locations - Aligarh, Sitarganj. Ahmedabad and Sikkim. It also has 8 co-packing facilities in India, Oman and Newzealand. Its core pillars -manufacturing integrity, supply chain efficiency, and product innovation, form the basis of the legacy it has built over the last few decades. Currently the Zydus Wellness business spans over several countries and many continents. It combines the best of healthcare, nutrition and cosmeceutical products to provide quality wellness products. It helps people pursue integrated well-being through its widening range of products.
Business area of the company
The company is an integrated consumer company. The Company is engaged in the development, production, marketing and distribution of health and wellness products.
Product of the Company
The Company has a wide range of health and wellness products. The Company’s product portfolio includes popular brands with functional benefits like Glucon D, Complan, Sugar Free, Nycil, Everyuth, Nutralite and Sugarlite.
Awards
2017-18
- Its Sikkim plant received the Gold Award at the National Award for Manufacturing Competitiveness (NAMC), conducted by International Research Institute of Manufacturing.
- Its flagship brand Sugar Free won the ‘Best Integration of Brand and Movie’ award at the Prime Time Awards 2017 for its association with the Bollywood film, ‘Chef’.
- National Gold Award for Manufacturing Competitiveness.
2018-19
- The Sikkim plant was presented with the Gold award by the International Research Institute of Manufacturing.
- The Ahmedabad plant (Nutralite) was presented the Silver award by the International Research Institute of Manufacturing at the National Award for Manufacturing Competitiveness 2018.
- The Sikkim plant was presented the Silver award at the India Manufacturing Excellence Award held by Frost and Sullivan.
- The Company was presented the Best SLIM Lead Award for manufacturing facilities in an exercise organised by the Zydus group.
- Won the India Packaging Award for Sugar Free Green Veda pack for Excellence in Packaging Design.
- Won three Inflection Awards for the Best Procurement Team of the Year, 2018.
- Sugar Free won the Gold Award at Abby Awards (Publishers) for the Company’s West Bengal initiative with ABP.
2019-20
- Most Trusted Brands 2020
Milestones
- 1988: Launched Sugar Free with Aspartame.
- 1991: Launched the Everyuth skincare range.
- 2005: Introduced Sugar Free Natura with Sucralose.
- 2006: Acquired Carnation NutraAnalogue Foods Ltd.
- 2009: Restructured the consumer business of Cadila Healthcare Ltd., renamed Zydus Wellness Ltd.
- 2011: Inaugurated the manufacturing plant in Sikkim.
- 2017: Commissioned the new production facility in Sikkim.
- 2017: Launched Sugar Free Green with Stevia.
- 2018: Introduced Nutralite Mayonnaise in three appealing flavours: vegetable, cheese garlic and achari.
- 2019: Acquired Heinz India Pvt. Ltd.
You have 3 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
